• OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • Partner and Localizer of BRCA2 (PALB2) Gene Mutation Analysis
  • Hepatic Function Panel (Liver Panel)
  • DNA Cell Cycle Analysis by Flow Cytometry
  • MLH1 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • NTRK Gene Fusion Panel (NTRK1, NTRK2, and NTRK3), Solid Tumors
  • Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Gene Mutation Analysis (Translocation)
  • Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Medical Test

Turnaround Time
Access to MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue is restricted.
Loading...